REDUCING OVERPAYMENTS OF INFUSION DRUGS.

SEC. 5004. REDUCING OVERPAYMENTS OF INFUSION DRUGS. (a) Treatment of Infusion Drugs Furnished Through Durable Medical Equipment.—Section 1842(o)(1) of the Social Security Act (42 U.S.C. 1395u(o)(1)) is amended— (1) in subparagraph (C), by inserting “(and including a drug or biological described in subparagraph (D)(i) furnished on or after January 1, 2017)” after “2005”; and (2) in subparagraph (D)— (A) by striking “infusion drugs” and inserting “infusion drugs or biologicals” each place it appears; and (B) in clause (i)— (i) by striking “2004” and inserting “2004, and before January 1, 2017”; and (ii) by striking “for such drug”. (b) Noninclusion of DME Infusion Drugs Under DME Competitive Acquisition Programs.— (1) In general.—Section 1847(a)(2)(A) of the Social Security Act (42 U.S.C. 1395w-3(a)(2)(A)) is amended— (A) by striking “and excluding” and inserting “, excluding”; and (B) by inserting before the period at the end the following: “, and excluding drugs and biologicals described in section 1842(o)(1)(D)”. (2) Conforming amendment.—Section 1842(o)(1)(D)(ii) of the Social Security Act (42 U.S.C. 1395u(o)(1)(D)(ii)) is amended by striking “2007” and inserting “2007, and before the date of the enactment of the 21st Century Cures Act.”.